According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are HK$45.66 Million. In 2023 the company made an earning of HK$91.38 Million, an increase over its 2022 earnings that were of -HK$92.27 Million. The earnings displayed on this page is the company's Pretax Income.